ALK+ ALCL tumor cells also develop ALK TKI resistance through amplification of NPM–ALK, which was shown to be overexpressed in ALK+ALCL-resistant cell lines (48, 55, 57, 58). This evidence concerns the gene ALK and anaplastic large cell lymphoma.